ArticleBMC medical imaging2025
A Stepwise decision tree model for differential diagnosis of Kimura's disease in the head and neck.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Comprehensive Review of Kimura Disease.Head and neck pathology · 2025Pooled it
- Therapeutic Efficacy of Anti-Interleukin-5 Monoclonal Antibodies in Kimura Disease: A Systematic Review.Cureus · 2026Review
- Retroauricular Kimura Disease in a Young European Female: A Rare Case and Review of the Literature.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesThis study aims to differentiate Kimura's disease (KD) from Sjogren's syndrome with mucosa-associated lymphoid tissue lymphoma (SS&MALT), neurofibromatosis (NF), and lymphoma in the head and neck by using a stepwise decision tree approach. MATERIALS AND
methodsA retrospective analysis of 202 patients with pathologically confirmed KD, SS&MALT, NF, or lymphoma was conducted. Demographic and magnetic resonance imaging (MRI) data were collected, with qualitative features (e.g., skin thickening, lesion morphology, lymphadenopathy, MRI signal intensity) and quantitative variables (e.g., age, lesion size, apparent diffusion coefficients (ADCs), wash-in rate, time to peak (TTP), time-signal intensity curve (TIC) patterns) examined. A stepwise decision-tree model using the classification and regression trees (CART) algorithm was developed to aid in the differential diagnosis of KD in the head and neck. The model's diagnostic accuracy and misclassification risk were assessed to evaluate its reliability and effectiveness.
resultsKey characteristics for KD included male predominance (91.7%), frequent lymphadenopathy (86.1%), and skin thickening (72.2%). Primary lesions of NF typically exhibited higher ADCs compared to those of KD, SS&MALT, and lymphoma. In lymphadenopathy, however, unique ADC patterns were observed: in KD, the ADCs of lymphadenopathy were lower than those of primary lesions, whereas in lymphoma, the ADCs of lymphadenopathy were comparable to those of primary lesions. Predictors for distinguishing KD included lesion's location, ADCs, lymphadenopathy, and sizes (all p < 0.001). The decision-tree model achieved an impressive 99.0% accuracy in the differential diagnosis across the overall cohort, with a 10-fold cross-validated misclassification risk of 0.079 ± 0.024.
conclusionThe stepwise decision tree model, based on MRI features, showed high accuracy in differentiating KD from other head and neck diseases, offering a reliable diagnostic tool in clinical practice. CLINICAL RELEVANCE: KD is characterized by male predominance, skin thickening, and high incidence of lymphadenopathy. ADCs and TIC patterns are distinguishable in differentiating KD from SS&MALT, NF, and lymphoma in the head and neck. The decision tree model enhances the understanding of KD imaging features and facilitates accurate KD diagnosis, offering an easily accessible and convenient diagnostic tool for radiologists and physicians in daily practice and guiding tailored clinical management plans for affected patients. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.